Cargando…
Age-Related Medicine
A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk–benefit ratio of a medicine changes as an individual...
Autores principales: | Wahlich, John, Orlu, Mine, Mair, Alpana, Stegemann, Sven, van Riet-Nales, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523864/ https://www.ncbi.nlm.nih.gov/pubmed/30970554 http://dx.doi.org/10.3390/pharmaceutics11040172 |
Ejemplares similares
-
Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
por: Stegemann, Sven, et al.
Publicado: (2020) -
Actual versus recommended storage temperatures of oral anticancer medicines at patients’ homes
por: Vlieland, ND, et al.
Publicado: (2017) -
Nanomedicines for the Delivery of Biologics
por: Wahlich, John, et al.
Publicado: (2019) -
Coming of age of personalized medicine: challenges ahead
por: Borry, Pascal
Publicado: (2009) -
Oral Medicines for Children in the European Paediatric Investigation Plans
por: van Riet – Nales, Diana A., et al.
Publicado: (2014)